CD99 is a therapeutic target on disease stem cells in myeloid malignancies-Reference-Cited by-同舟云学术

CD99 is a therapeutic target on disease stem cells in myeloid malignancies

Published:2017-01-25 Issue:374 Volume:9 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Chung Stephen S.¹²,Eng William S.¹,Hu Wenhuo¹,Khalaj Mona¹³,Garrett-Bakelman Francine E.⁴,Tavakkoli Montreh¹,Levine Ross L.¹²,Carroll Martin⁵,Klimek Virginia M.²,Melnick Ari M.⁴,Park Christopher Y.¹⁶

Affiliation:

1. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

2. Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

3. Weill Graduate School of Medical Sciences, Cornell University, New York, NY 10065, USA.

4. Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell School of Medicine, New York, NY 10065, USA.

5. Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.

6. Departments of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Abstract

CD99 is a potential therapeutic target enriched on disease stem cells in myeloid malignancies.

Funder

Doris Duke Charitable Foundation

Leukemia and Lymphoma Society

Geoffrey Beene Cancer Research Center

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference59 articles.

1. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

2. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

3. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region

4. Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9

5. Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced T cell activation and cytotoxicity against AML via targeted anti-CD99 nanoparticle treatment;Biomedicine & Pharmacotherapy;2024-10

2. Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AML;Blood Advances;2024-08-30

3. FLT3/CD99 Bispecific Antibody–Based Nanoparticles for Acute Myeloid Leukemia;Cancer Research Communications;2024-08-01

4. Machine learning analysis of gene expression reveals TP53 Mutant-like AML with wild type TP53 and poor prognosis;Blood Cancer Journal;2024-05-14

5. Recent advances in CAR‐T cell therapy for acute myeloid leukaemia;Journal of Cellular and Molecular Medicine;2024-05